title: Editorial Comment to Efficacy and tolerance of one-third full dose bacillus Calmette-Guérin maintenance therapy every 3 months or 6 months: two-year results of URO-BCG-4 multicenter study.
authors.affiliation: Department of Urology, The Christie Hospital, Manchester, UK. richard.robinson@christie.nhs.uk.
authors.forename: Richard
authors.initials: R
authors.lastname: Robinson
mesh_terms: D001500:BCG Vaccine / Q000008:administration & dosage*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
chemical_list: D001500:BCG Vaccine